Market Tracker

08/25 2:40pm ET
78.16
BATS BZX Real-Time Price
As of 2:40pm ET
 -0.28 / -0.36%
Today’s Change
67.88
Today|||52-Week Range
92.85
-7.24%
Year-to-Date
Eli Lilly, AstraZeneca Alzheimer's Drug Gets FDA Fast Track
Aug 23 / Zacks.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
Intermediate Level Trade: Eli Lilly
Aug 22 / TheStreet.com - Paid Partner Content
Novo Nordisk A/S Focuses on New Drugs
Aug 16 / MotleyFool.com - Paid Partner Content
Pharmaceuticals: Staying power
Aug 21 / FT.com - Paid Partner Content
Epizyme Doses First Patient in Phase II Mesothelioma Study
Aug 15 / Zacks.com - Paid Partner Content
US doctors waste millions on branded medicines
Aug 21 / FT.com - Paid Partner Content
Drugmakers hooked on $10bn opioid habit
Aug 10 / FT.com - Paid Partner Content

Today’s Trading

Previous close78.44
Today’s open78.34
Day’s range78.13 - 79.16
Volume113,320
Average volume (3 months)3,965,985
Market cap$86.6B
Dividend yield2.61%
Data as of 2:40pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+4.46%
Earnings growth (next 5 years)+14.20%
Revenue growth (last year)+1.75%
P/E ratio33.8
Price/Sales4.50
Price/Book5.95

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-2.44-2.21%
AZNAstraZeneca-0.25-0.75%
NVONovo Nordisk+0.04+0.09%
AGNAllergan-8.71-3.58%
Data as of 2:40pm ET, 08/25/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.95
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts